CAMBRIDGE, Mass.--(www.gnubio.com a pioneer in the Desktop DNA sequencing market, announced today that John Boyce, President and Chief Executive Officer of GnuBIO, will present at the Cowen and Company 33rd Annual Health Care Conference on Tuesday, March 5 at 8:30 a.m. EST, at the Boston Marriott Copley Place in Boston.)--GnuBIO, Inc. (GnuBIO),
GnuBIO, Inc. (www.gnubio.com) is a private company and a pioneer in the field of scalable DNA sequencing technology for the Diagnostic and Applied Markets. Utilizing its proprietary microfluidic and emulsion technologies, GnuBIO will work within these markets to develop nucleic acid analysis based systems that scale as a function of both patient sample and genomic region. The GnuBIO system has the capability of running numbers of samples that are in line with diagnostic and applied market requirements for a cost that is orders of magnitude lower than with current technology.
The GnuBIO system has a completely integrated workflow, inclusive of genomic selection, amplification, sequencing and real time informatics (assembly and variant calling), allowing researchers and clinicians to simply inject genomic DNA, and walk away – with data on the target regions in a few hours.